Why Investors Shouldn’t Be Surprised By Bruker Corporation’s (NASDAQ:BRKR) 31% Share Price Plunge
Explore Bruker’s Fair Values from the Community and select yours
The Bruker Corporation (NASDAQ:BRKR) share price has fared very poorly over the last month, falling by a substantial 31%. The recent drop completes a disastrous twelve months for shareholders, who are sitting on a 51% loss during that time.
Although its price has dipped substantially, Bruker may still look like a strong buying opportunity at present with its price-to-sales (or “P/S”) ratio of 1.3x, considering almost half of all companies in the Life Sciences industry in the United States have P/S ratios greater than 3.5x and even P/S higher than 6x aren’t out of the ordinary. However, the P/S might be quite low for a…
